Christina is the CEO of 2NA FISH, a pre-seed startup developing novel cancer diagnostics for making better therapy decisions. She's amolecular biologist by training, and an entrepreneur at heart. After finishing her PhD in RNA and adipose tissue biology at the Helmholtz Center Munich in 2017, she realized that entrepreneurship lets her provide value to the world more directly than staying in academia. She started 2NA FISH at the LMU in 2020, has since raised more than 1.5 million € in non-dilutive grants and built a thriving team of excellent scientists, business people and software experts. Today, she and her team are working on shifting the paradigm for more data-driven therapy decisions in cancer treatment.
Medizinische Bilder sind keine neutralen Abbilder, sondern Entscheidungen im Entstehen. Zwischen Mikroskop, Algorithmus und Atelier treffen unterschiedliche Formen des Sehens aufeinander: klinische Praxis, KI-gestützte Diagnostik und künstlerische Forschung. Diese Session bringt …
